Feugiat nulla facilisis at vero eros et curt accumsan et iusto odio dignissim qui blandit praesent luptatum zzril.
+ (123) 1800-453-1546

Related Posts

Our Mission: Innovating to Protect Humanity from the Global Threat of Antimicrobial Resistance: Integrating Solutions Across Human and Veterinary Medicine, Stewardship, and Awareness

profileImage.img.png

We are excited to welcome Tim van Opijnen, PhD, an Associate Professor of Biology at Boston College and an Affiliate member of the Levy CIMAR, to present for our May 2021 Science Lunch. His talk is titled,  “From Detection to […]

image

The Levy CIMAR’s own Dr. Andrew Camilli, a Professor of Molecular Biology and Microbiology at the Tufts University School of Medicine, will present on “Phage Prophylaxis of Cholera.” Bacteriophages are viruses that specifically target and kill bacteria, preventing bacterial infections, […]

EyPkBFEWYAQPgnc

Erin Duffy, PhD, is Chief of Research and Development at the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X—a global partnership hosted at Boston University that is focused on supporting developers of promising new antibiotics, diagnostics, and vaccines that tackle the […]

In the first six months of the pandemic, 52% of hospitalized #COVID19 patients in the U.S. received at least one #antibiotic -- yet only a fraction of these patients had common bacterial infections. https://t.co/IJ8FiQwTA3 @SaraTheIceBerg via @AmerMedicalAssn

We need more action, less talk on #AMR ⁦@LevyCIMAR⁩ ⁦@IDSAInfo⁩ ⁦@ARLGnetwork⁩ ⁦@JeremyFarrar⁩ ⁦@UKAMREnvoy⁩ ⁦@CARB_X⁩ ⁦@Wellcome_AMR⁩ https://t.co/bCQ5A4a0rT

Load More...